Last updated on September 2015

Lupus Nephritis


Brief description of study

Lupus Nephritis

Detailed Study Description

The drug being tested is called belimumab. It is a prescription medicine to treate active systemic lupus erythematosus who are receiving other lupus medicines. The purpose of the study is to find out if belimumab is effective and safe in treating patients with active lupus nephritis who are receiving other standard lupus nephritis medicines.

Clinical Study Identifier: TX141478

Find a site near you

Start Over

Northeast Clinical Research Center, LLC.

2014 City Line Rd.<br /> Suite 103 Bethlehem, PA USA
  Connect »